Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Oxford Biomedica plc    OXB   GB00BDFBVT43

OXFORD BIOMEDICA PLC

(OXB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société OXFORD BIOMEDICA PLC
10/06OXFORD BIOMEDICA : notes Axovant's positive six-month follow-up from second coho..
PU
10/06OXFORD BIOMEDICA : notes Axovant's positive six-month follow-up from second coho..
AQ
10/06Oxford Biomedica notes Axovant's positive six-month follow-up from second coh..
GL
10/06OXFORD BIOMEDICA : receives MHRA approval for fourth manufacturing suite in Oxbo..
PU
09/17OXFORD BIOMEDICA : Interim results for the six months ended 30 june 2020
AQ
09/17Oxford biomedica plc interim results for the six months ended 30 june 2020
GL
09/17OXFORD BIOMEDICA : OXB Interim Results FY20 RNS FINAL.pdf
PU
09/17OXFORD BIOMEDICA : interim results for thesix months ended 30 June 2020
PU
09/01THE LATEST : Children in Wuhan return to school
AQ
09/01THE LATEST : 900,000 in Finland download virus tracing app
AQ
09/01OXFORD BIOMEDICA : Signs Supply Agreement with AstraZeneca to Expand Manufacturi..
PU
08/27OXFORD BIOMEDICA : Notice of Interim Results
PU
08/03OXFORD BIOMEDICA : Summary Toggle Axovant Signs Three-Year Clinical Supply Agree..
AQ
08/03OXFORD BIOMEDICA : Signs Development, Manufacture & License Agreement with Beam ..
PU
07/31OXFORD BIOMEDICA : Signs Three Year Clinical Supply Agreement with Axovant Gene ..
PU
07/20OXFORD BIOMEDICA : notes interim results from AstraZeneca on AZD1222 showing str..
PU
06/24ANNUAL GENERAL MEETING : Questions and Answers
PU
06/23OXFORD BIOMEDICA : Annual General Meeting
PU
06/19OXFORD BIOMEDICA : Information in Relation to Annual General Meeting
PU
06/13OXFORD BIOMEDICA : AstraZeneca to deliver Oxford-developed COVID-19 vaccine once..
AQ
06/08Oxford Biomedica Signs Five Year Collaboration Agreement with the Vaccines Ma..
GL
06/01OXFORD BIOMEDICA : Appoints Dr. Roch Doliveux as Non-Executive Chairman
PU
06/01Dr Roch Doliveux appointed Non-Executive Chairman
GL
05/28OXFORD BIOMEDICA : AstraZeneca strikes deal with Oxford Biomedica to make COVID-..
AQ
05/28Oxford Biomedica Signs Clinical & Commercial Supply Agreement with AstraZenec..
GL
05/22OXFORD BIOMEDICA : 2019 Annual report and Accounts & AGM Notification
PU
05/06Oxford Biomedica plc Preliminary results for the year ended 31 December 2019
GL
05/06OXFORD BIOMEDICA : Preliminary results for the year ended 31 December 2019
PU
04/22OXFORD BIOMEDICA : notes the announcement that Kymriah® has received FDA Regener..
PU
04/08OXFORD BIOMEDICA : joins Consortium to rapidly develop a COVID-19 vaccine candid..
PU
03/18OXFORD BIOMEDICA : Building the Group for future growth
PU
03/18OXFORD BIOMEDICA : Signs License & Clinical Supply Agreement with Juno Therapeut..
PU
03/18OXFORD BIOMEDICA : License & Supply Agreement with Juno Therapeutics
PU
03/18OXFORD BIOMEDICA : Business Update
PU
02/26OXFORD BIOMEDICA : Director Dealings / Market Share Purchase
PU
02/03OXFORD BIOMEDICA : Class 2 Transaction Announcement
PU
02/03OXFORD BIOMEDICA : Director Dealings / Market Share Purchase
PU
01/22OXFORD BIOMEDICA : Block listing Application
PU
2019OXFORD BIOMEDICA : Director Dealings / Market Share Purchase
PU
2019OXFORD BIOMEDICA : Extension of Commercial Supply Agreement
PU
2019OXFORD BIOMEDICA : Extends Commercial Supply Agreement by Five Years for Manufac..
PU
2019OXFORD BIOMEDICA : Director Dealings / Market Share Purchase
PU
2019OXFORD BIOMEDICA : Director Dealings / Market Share Purchase
PU
2019OXFORD BIOMEDICA : Director Dealings / Market Share Purchase
PU
2019OXFORD BIOMEDICA : Directors Dealings / Market Share Purchases
PU
2019OXFORD BIOMEDICA : Long Term Incentive Plan Option Grant
PU
2019OXFORD BIOMEDICA : Directors Dealings / Market Share Purchases
PU
2019OXFORD BIOMEDICA : Director Dealings / Market Share Purchase
PU
2019OXFORD BIOMEDICA : Interim Results
PU
2019OXFORD BIOMEDICA : Interim results for the six months ended 30 June 2019
PU
2019OXFORD BIOMEDICA : Director Dealings / Market Share Purchase
PU
2019OXFORD BIOMEDICA : Director Dealings / Market Share Purchase
PU
2019OXFORD BIOMEDICA : Repayment of Debt Facility
PU
2019OXFORD BIOMEDICA : Director Dealings / Market Share Purchase
PU
2019OXFORD BIOMEDICA : and Santen enter R&D collaboration and Option & Licence Agree..
PU
2019OXFORD BIOMEDICA : Board Change
PU
2019OXFORD BIOMEDICA : notes Axovant's six-month update from first cohort of Sunrise..
PU
2019OXFORD BIOMEDICA : Exercise of Subscription Option by Novo Holdings
PU
2019OXFORD BIOMEDICA : announces strategic investment by Novo Holdings A/S
PU
2019OXFORD BIOMEDICA : Strategic Investment by Novo Holdings A/S
PU
2019OXFORD BIOMEDICA : Director Dealings / Market Share Purchase
PU
2019OXFORD BIOMEDICA : Long Term Incentive Plan Option Grant
PU
2019OXFORD BIOMEDICA : to present at the Annual Meeting of the American Society of G..
PU
2019OXFORD BIOMEDICA : notes that Axovant has announced the dosing of the first pati..
PU
2019OXFORD BIOMEDICA : Axovant doses second cohort of AXO-Lenti-PD
PU
2019OXFORD BIOMEDICA : Director Dealings / Market Share Purchase
PU
2019OXFORD BIOMEDICA : Deferred Bonus Plan and LTIP Option Grants
PU
2019OXFORD BIOMEDICA : Director Dealings / Market Share Transactions
PU
2019OXFORD BIOMEDICA : Exercise of warrants
PU
2019OXFORD BIOMEDICA : Annual Report and Accounts & AGM Notification
PU
2019OXFORD BIOMEDICA : Director Dealings / Market Share Purchase
PU
2019OXFORD BIOMEDICA : notes the Japanese approval of Kymriah® (tisagenlecleucel), t..
PU
2019OXFORD BIOMEDICA : Japanese approval of Kymriah® (tisagenlecleucel)
PU
2019OXFORD BIOMEDICA PLC : Preliminary results for the year ended 31 December 2018
GL
2019OXFORD BIOMEDICA : Preliminary Results
PU
1  2Next
Upcoming event on OXFORD BIOMEDICA PLC